Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
70,600
+17,600
+33% +$258K ﹤0.01% 6434
2025
Q4
$670K Buy
53,000
+38,900
+276% +$574K ﹤0.01% 7065
2025
Q3
$217K Sell
14,100
-20,400
-59% -$329K ﹤0.01% 9522
2025
Q2
$542K Buy
+34,500
New +$523K ﹤0.01% 6766
2024
Q1
Sell
-130,900
Closed -$3.04M 9963
2023
Q4
$3.04M Buy
130,900
+109,800
+520% +$2.21M ﹤0.01% 3610
2023
Q3
$416K Buy
+21,100
New +$416K ﹤0.01% 6561
2023
Q1
Sell
-66,600
Closed -$1.13M 9800
2022
Q4
$1.13M Buy
+66,600
New +$1.18M ﹤0.01% 4786

Other funds holding RXO

Jane Street's RXO Position: Q1 2026 in Review

Jane Street sold out of RXO (RXO) in Q1 2026, closing a stake of 310,254 shares — an estimated $4.55M sold.

Jane Street first reported a position in RXO in Q4 2022 and held it in 10 quarters. The position peaked at $9.42M in Q3 2024. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Jane Street reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 310,254 RXO shares in Q1 2026, an estimated $4.55M.
  • Jane Street first reported a position in RXO in Q4 2022 and held it in 10 quarters.
  • Jane Street's RXO position peaked at $9.42M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.